In-depth analyses further revealed that α2,6-sialyltransferase, ST6GAL1, was a novel E6-induced oncogenic protein and performed oncogenic activities in both E6-positive and E6-negative cervical cancer cells. The gene discussed is ST6GAL1; the disease is cervical cancer.